Exactech Knee Lawsuit Filed Over Recalled Optetrak Polyethylene Liner

Following an Exactech knee recall issued last month, a New York woman has filed a product liability lawsuit alleging that she received one of the defective Optetrak polyethylene liners, which failed prematurely and caused her to undergo an early revision surgery.

More than 140,000 Exactech Optetrak, Optetrak Logic, Truliant and Vantage implants distributed since 2004 were impacted by the recall, after the manufacturer disclosed that โ€œout-of-specificationโ€ vacuum bags were used with a plastic polyethylene insert component.

This defective packaging allowed oxygen to reach the plastic inserts before they were implanted, causing the component to oxidize and wear out much earlier than expected, or become damaged after it is inside in the body. As a result, thousands of individuals throughout the United States who experienced complications with their Exactech knee replacements in recent years are just now learning that their problems were caused by a manufacturing defect.

In a complaint (PDF) filed last week in the U.S. District Court for the Southern District of New York, Leslie Liberatore alleges her Exactech Optetrak knee failed seven years after it was implanted, leaving her with permanent and disabling injuries.

According to the lawsuit, Liberatore underwent bilateral total knee replacement surgery in March 2012, which included size 3.9 mm Optetrak Logic Tibial inserts made of polyethylene. However, in April 2019, she required additional revision surgery after she developed aseptic loosening and osteolysis in her left knee. She has now discovered the problems she experienced were a direct result of the defective packaging.

โ€œAs a result of Defendantsโ€™ failure to properly package the Optetrak Device prior to distribution, the polyethylene liner prematurely degraded and Plaintiff required revision surgeries due to severe pain, swelling, and instability in the knee and leg,โ€ Liberatoreโ€™s lawsuit states. โ€œThese injuries were caused by early and preventable wear of the polyethylene insert, and resulting component loosening and/or other failures causing serious complications including tissue damage, osteolysis, permanent bone loss and other injuries.โ€

In the wake of the revision surgery, Liberatore says she continues to be limited in her daily activities and has difficulty getting dressed, climbing stairs, and bathing. In addition, she suffers daily pain and discomfort in her knees, impacting her quality of life, the lawsuit indicates.

Exactech Optetrak Knee Lawsuits

The case joins a growing number of Exactech knee lawsuits now being filed by individuals who experienced problems with an Optetrak, Optetrak logic or Truliant implant received in recent years, indicating that the manufacturer knew or should have known about the issues much earlier, given the abysmal knee failure rates associated with the implants.

As early as 2017, lawsuits over Exactech knee implants indicated that there were alarming rates of adverse event reports being submitted to the FDA, which resulted in what some said was a โ€œsilentโ€ Exactech knee recall when the company began slowly and quietly replacing the tibial trays of some Optetrak models.

The Exactech Optetrak knee replacement system was introduced through the FDAโ€™s controversial 510(k) fast-track approval process, meaning the manufacturer did not have to undergo extensive testing for safety and effectiveness, but only needed to show the device was โ€œsubstantially equivalentโ€ to existing devices.

The recent Exactech recall notice now suggests manufacturing changes in about 2004 caused knee replacements to be shipped with โ€œnon-conformingโ€ vacuum bags which failed to protect the polyethylene inserts.

While Exactech has indicated it intends to cover all recall-related โ€œout-of-pocketโ€ expenses incurred by patients, limited information has been provided about what rights claimants may give up by seeking this limited reimbursement, when the true value of any knee replacement settlementsย through a personal injury lawsuit would be substantially higher.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

In a joint statement, plaintiffs and defendants in AngioDynamics port catheter lawsuits have laid guidelines for what types of cases should be selected to serve as potential bellwether trials.
Women who experienced infection, chronic inflammation, implant instability or other complications after internal bra mesh procedures are now questioning whether those risks were fully disclosed before implantation.
More than 3,300 women have filed Depo-Provera lawsuits in federal court, with several hundred more also pending in state courts in New York and Delaware, according to a recent status report.